HFpEF - Heart Failure With Preserved Ejection Fraction Clinical Trials
2 recruiting trials for HFpEF - Heart Failure With Preserved Ejection Fraction. Eligibility criteria explained in plain English.
2
Total Trials
2
Recruiting Now
0
Phase 3 Trials
2
Sponsors
Recruiting Trials
RECRUITINGPhase 2NCT07221513
Study of JK07 in Patients With Heart Failure and WHO Group 2 Combined Post- and Pre-Capillary Pulmonary Hypertension
This is a Phase 2a, open-label, multiple-dose study to assess the safety, tolerability, and efficacy of JK07 in participants 18 to 85 years of age with diagnosed HF and cpcPH. At...
Sponsor: Salubris Biotherapeutics IncEnrolling: 301 location
RECRUITINGPhase 2 / Phase 3NCT07223242
Tailored Exercise Training Study Among Adults With HFpEF
Heart failure with preserved ejection fraction (HFpEF) is associated with a high morbidity and mortality burden. There are limited pharmacological options available for the...
Sponsor: University of Texas Southwestern Medical CenterEnrolling: 1201 location